Mono Pharmacare Q4 Results
- BSE: -
- NSE: MONOPHARMA
- ISIN: INE0OIP01012
- Sector: Biotechnology & Drugs
BSE
This stock is not traded on BSE
NSE
11.50
-0.40 (-3.36%)
-0.40 (-3.36%)Volume12.00 K
Updated: Mon 16 Feb, 2026 | 13:55:44
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Mono Pharmacare Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | - | QoQ Comp | Mar 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 78.34 | - | N/A | 33.12 | 46.67% |
| Depreciation/ Amortization | 0.06 | - | N/A | 0.07 | 0.62% |
| Operating Income | 2.84 | - | N/A | 1.91 | 18.54% |
| Net Income | 0.80 | - | N/A | 0.64 | 42.10% |
| Other Operating Expenses Total | 3.24 | - | N/A | 0.81 | 153.81% |
| Net Income Before Taxes | 1.31 | - | N/A | 1.03 | 51.10% |
| Total Revenue | 81.18 | - | N/A | 35.03 | 45.46% |
| Selling/ General/ Admin Expenses Total | 2.08 | - | N/A | 0.88 | 22.55% |
| Diluted Normalized EPS | 0.45 | - | N/A | 0.22 | 37.86% |